Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
4 papers
Recent·Most cited
S. Udutha, C. Taglang, G. Batsios…·P. Viswanath
This study identifies metabolic vulnerabilities in glioblastomas driven by TERT and shows that combining GCLC and glutamine-utilizing enzyme inhibitors synergistically targets these vulnerabilities.
E. Roider, A. I. T. Lakatos, A. M. McConnell…·D. E. Fisher
The paper shows MITF promotes melanoma survival by increasing resistance to reactive oxygen species through regulating antioxidant genes like IDH1 and NNT.
K. Song, J. K. Minami, W. P. Crosson…·T. G. Graeber
This study investigates how BRAF amplifications in different genomic forms enable melanoma cells to adapt to targeted therapy dose changes, revealing mechanisms of drug resistance.
M. Masterman-Smith, N. A. Graham, E. Panosyan…·J. Sun
The paper uses single cell proteomic analysis to identify distinct signaling phenotypes in gliomaspheres, revealing EGFR and AKT/TORC1 signaling divergence and potential therapeutic targets.